Trusted Resource for Clinical Trials, Protocols & Progress
When regulatory authorities such as the FDA, EMA, or a sponsor audit a clinical research site, one of the earliest sections reviewed is training documentation. This set of essential records provides insight into whether trial personnel were qualified and informed about their responsibilities throughout the study.
Click to read the full article.
Training logs are essential to demonstrate that site personnel are properly qualified and trained to perform delegated trial tasks. However, missing signatures, unrecorded retraining, or incorrect version documentation in these logs is a common audit finding. When such errors are discovered—either during internal review, CRA monitoring, or inspections—sites must take prompt corrective actions to address the gaps and prevent recurrence.
Click to read the full article.
In clinical research, training documentation is not a one-time task—it is a lifecycle responsibility. The documentation of training activities must begin before site activation and continue throughout the duration of the trial. Regulatory inspections frequently scrutinize both initial and ongoing training documentation, and each has distinct compliance expectations.
Click to read the full article.
In clinical research, maintaining accurate and complete training documentation has always been a cornerstone of GCP compliance. Traditionally, this process relied on handwritten logs, printed certificates, and binders of sign-in sheets filed in the ISF. However, with increased regulatory scrutiny and the global shift to remote work, sponsors and sites are increasingly adopting digital tools to streamline training management.
Click to read the full article.
In clinical research, training documentation is not just an administrative task—it is direct evidence that site personnel are qualified and capable of performing trial-related duties. During routine monitoring visits, Clinical Research Associates (CRAs) are responsible for verifying that training logs are complete, accurate, and reflect all relevant updates including protocol amendments, new staff onboarding, and retraining after deviations.
Click to read the full article.
In the evolving landscape of clinical research, maintaining Good Clinical Practice (GCP) knowledge is not a one-time requirement. Regulatory authorities and sponsors expect site personnel to demonstrate ongoing awareness of GCP principles, protocol responsibilities, and ethical obligations. Annual GCP refresher training has become a standard requirement across many clinical trials, serving both as a compliance measure and as a way to reinforce investigator responsibilities.
Click to read the full article.
While Good Clinical Practice (GCP) principles are harmonized under ICH guidelines, individual countries impose their own continuing education mandates for clinical trial investigators and site staff. These mandates vary in frequency, content scope, acceptable formats (classroom vs digital), and enforcement mechanisms. For sponsors and Clinical Research Organizations (CROs) conducting multinational trials, understanding these national variations is critical to ensuring compliance and avoiding inspection findings.
Click to read the full article.
In clinical research, Standard Operating Procedures (SOPs) are living documents that must evolve to reflect protocol amendments, regulatory updates, or process improvements. When SOPs are revised, sites must ensure that affected staff are retrained on the latest procedures and that the training is documented in a GCP-compliant manner. Failure to do so can result in protocol deviations, inspection findings, or even subject safety risks.
Click to read the full article.
With the increasing complexity of clinical trials, regulators have emphasized the importance of continuing investigator education to uphold data integrity and subject safety. Education is no longer a one-time event at study initiation—it is now an ongoing requirement across multiple jurisdictions. Whether prompted by protocol amendments, regulatory updates, or evolving site expectations, authorities such as the FDA, EMA, and PMDA expect documentation of regular training activities tailored to trial roles.
Click to read the full article.
As regulatory requirements for Good Clinical Practice (GCP) training evolve, the demand for accredited and audit-compliant training platforms has grown significantly. Investigators, sub-investigators, site coordinators, and sponsor teams are now expected to complete and document GCP and protocol-specific education through platforms that meet validation and accreditation criteria.
Click to read the full article.
